RESEARCH

 

For the past decade fucoidans has been extensively studied due to their varied benefits.  These, independent studies suggest these benefits include, anticoagulant and antithrombotic, antivirus, antitumor and immunomodulatory, anti-inflammatory, blood lipids reducing, antioxidant and anticomplementary properties, activity against hepatopathy, uropathy and renalpathy, gastric protective effects and therapeutic potential in surgery.  Additionally, published papers have reported that fucoidan may exert a range of beneficial effects on the human immune system, including the reduction of allergic responses and the activation of dendritic cells, natural killer cells and T cells. It has also been shown that fucoidan has the potential to boost important anti-viral, anti-tumor and anti-aging responses.

PURPORTED USES

BOOST THE IMMUNE SYSTEM

Several human studies suggest it may stimulate immune functioning and boost antibody production after vaccination.

REDUCE

INFLAMMATION

Lab studies suggest that fucoidan has anti-inflammatory properties. Human studies are needed.

PREVENT CANCER & BLOOD CLOTS

Lab studies show that fucoidan has antitumor properties and it slows the production of blood clots. 

LOWER THE BLOOD PREASURE

A study in overweight and obese adults suggests that fucoidan used over a sustained period may decrease blood pressure and “bad” cholesterol levels. Confirming studies are needed.

CLINICAL STUDIES

According to the Memorial Sloan Kettering Cancer Center.  Fucoidan is a sulfated polysaccharide found in the cell walls of many species of brown seaweed. In vitro studies show that it has antitumor, antiangiogenic (1) (2) (3) (4) (5) (6), antiviral (10) (11), antiarthritic (12), and immunomodulatory (13) effects. Fucoidan also exhibited neuroprotective (14) (15), radioprotective (16), and antiulcer (17) properties.

Existing researches demonstrates that fucoidan can can eliminate tumor cells, delay tumor growth and synergize with anticancer chemotherapy drugs in vitro, in vivo and in clinical trials.  Additional research shows that Fucoidan can active natural killer cells and macropages that directly exert anti-cancer actions.  (19)

CANCER

IMMUNE SUPPORT

Fucoidan has been well-investigated for its immunostimulating effect. Immunostimulating means activating the body's immune system. By strengthening the immune system, living things can protect themselves.  Research has shows that fucoidan derived from Mozuku, fucoidan derived from Mekabu activates the body's Natural Killer Cells which strengthens the immune system (24).  Additionally,  Fucoidans show a wide spectrum of biological effects, such as anti-coagulant and anti-thrombotic properties, anti-viral, anti-tumor, immunomodulatory, anti-oxidant, and anti-complement functions

Because of its anticoagulant properties (7) (8), fucoidan may have additive effects with anticoagulants such as warfarin and heparin.

CONTRAINDICATIONS

ADVERSE REACTIONS

Diarrhea, which improved immediately after stopping fucoidan administration (18)

FREQUENTLY ASKED QUESTIONS

WHAT IS FUCOIDAN LONGEVITY BOOSTER?


This is a powerful anti-inflammatory antioxidant blend with rejuvenating properties. The main ingredient of this proprietary blend is fucoidan, a complex polysaccharide found in many species of brown seaweed. We will use “Nano Fucoidan Extract”.




WHAT IS NANO FUCOIDAN EXTRACT?


“Nano Fucoidan Extract” is produced from Okinawan mozuku fucoidan which is derived through a patented unique manufacturing process.




WHAT IS THE NANO FUCOIDAN EQUIVALENT TO IN ORDINARY FUCOIDAN?


36,000mg nano fucoidan (equivalent to 180,000mg of ordinary fucoidan) per container. This means you can take 1/5 of the nano fucoidan for the equivalent in ordinary fucoidan.




WHAT RESEARCH HAS BEEN DONE ON FUCOIDAN?


For the past decade fucoidans has been extensively studied due to their varied benefits. These, independent studies suggest these benefits include, anticoagulant and antithrombotic, antivirus, antitumor and immunomodulatory, anti-inflammatory, blood lipids reducing, antioxidant and anticomplementary properties.




WHEN WILL THE PRODUCT BE AVAILABLE?


The Company estimates that it will launch these products under the Commodity Wellness name in July 2021.




WHAT WILL THE FUCOIDAN LONGEVITY BOOSTER CONTAIN?


We are currently finalizing the product formula. But we expect the initial product will be a capsule.




WHAT IS THE EFFECTIVE DOSAGE OF FUCOIDAN?


Based on the results of various research conducted by the Foundation Research Lab, we recommend that you take at least 1 to 2 g of fucoidan to fight adult lifestyle-related diseases, or at least 3 to 6 g to fight cancer and other malignant diseases. Since the activity of immune cells that control immunity increases in the active period (daytime) and decreases in the inactive period (nighttime), taking fucoidan four times a day (morning, noon, night, before sleep) should boost the immune cells more effectively.




WHAT ARE THE BENEFITS OF FUCOIDAN?


Fucoidan has been shown to be effective in preventing/treating diabetes, hypertension and other adult lifestyle-related diseases, gastric ulcer, and allergy (including atopic dermatitis and pollinosis). ​According to information published by Memorial Sloan Kettering Cancer Center as of January 2021, studies on fucoidan suggest that it can prevent the growth of cancer cells and has antiviral, neuroprotective, and immune-modulating effects. Other benefits include anti-inflammatory, anti-coagulant (prevents blood clotting), anti-thrombotic (reduces the formation of clots), anti-angiogenic (reduces the growth of new blood vessels), anti-viral, anti-tumor, and anti-oxidant effects on the body.





REFERENCES

  1. Maruyama H, Tamauchi H, Hashimoto M, Nakano T. Antitumor activity and immune response of Mekabu fucoidan extracted from Sporophyll of Undaria pinnatifida. In Vivo 2003; 17(3):245-249.

  2. Haneji K, Matsuda T, Tomita M et al. Fucoidan extracted from Cladosiphon okamuranus tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. Nutr Cancer 2005; 52(2):189-201.

  3. Liu JM, Bignon J, Haroun-Bouhedja F et al. Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin. Anticancer Res 2005; 25(3B):2129-2133.

  4. Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 2003; 65(2):173-179.

  5. Alekseyenko TV, Zhanayeva SY, Venediktova AA, et al. Antitumor and antimetastatic activity fucoidan, a sulfated polysaccharide isolated from the Okhotsk Sea Fucus evanescens brown alga. Bull Exp Biol Med. 2007 Jun;143(6):730-2.

  6. Nagamine T, Hayakawa K, Kusakabe T, et al. Inhibitory effect of fucoidan on Huh7 hepatoma cells through downregulation of CXCL12. Nutr Cancer. 2009;61(3):340-7.

  7. Colliec S, Fischer AM, Tapon-Bretaudiere J, et al. Anticoagulant properties of a fucoïdan fraction. Thromb Res. 1991 Oct 15;64(2):143-54.

  8. Irhimeh MR, Fitton JH, Lowenthal RM. Pilot clinical study to evaluate the anticoagulant activity of fucoidan. Blood Coagul Fibrinolysis. 2009;20: 607-610.

  9. Church FC, Meade JB, Treanor RE, Whinna HC. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin. J Biol Chem. 1989 Feb 25;264(6):3618-23.

  10. Lee JB, Hayashi K, Hashimoto M, Nakano T, Hayashi T. Novel antiviral fucoidan from sporophyll of Undaria pinnatifida (Mekabu). Chem Pharm Bull (Tokyo). 2004 Sep;52(9):1091-4.

  11. Hayashi K, Nakano T, Hashimoto M, Kanekiyo K, Hayashi T. Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. Int Immunopharmacol. 2008 Jan;8(1):109-16.

  12. Shu Z, Shi X, Nie D, et al. Low-Molecular-Weight Fucoidan Inhibits the Viability and Invasiveness and Triggers Apoptosis in IL-1beta-Treated Human Rheumatoid Arthritis Fibroblast Synoviocytes. Inflammation. Oct 2015;38(5):1777-1786.

  13. Raghavendran HR, Srinivasan P, Rekha S. Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats. Int Immunopharmacol. 2011 Feb;11(2):157-63.

  14. Luo D, Zhang Q, Wang H, et al. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Eur J Pharmacol. 2009 Sep 1;617(1-3):33-40.

  15. Do H, Pyo S, Sohn EH. Suppression of iNOS expression by fucoidan is mediated by regulation of p38 MAPK, JAK/STAT, AP-1 and IRF-1, and depends on up-regulation of scavenger receptor B1 expression in TNF-alpha- and IFN-gamma-stimulated C6 glioma cells. J Nutr Biochem. 2010 Aug;21(8):671-9.

  16. Byon YY, Kim MH, Yoo ES, et al. Radioprotective effects of fucoidan on bone marrow cells: improvement of the cell survival and immunoreactivity. J Vet Sci. 2008 Dec;9(4):359-65.

  17. Choi JI, Raghavendran HR, Sung NY, et al. Effect of fucoidan on aspirin-induced stomach ulceration in rats. Chem Biol Interact. 2010 Jan 5;183(1):249-54.

  18. Araya N, Takahashi K, Sato T, et al. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease. Antivir Ther. 2011;16(1):89-98.

  19. Yuan Lin, Xingsi Qi, Hengjian Liu, Kuijin Xue, Shan Xu & Zibin Tian, The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations

  20. Wei Zhang, Tatsuya Oda, Qing Yu, and Jun-O Jin, Fucoidan from Macrocystis pyrifera Has Powerful Immune-Modulatory Effects Compared to Three Other Fucoidans

  21. Li B., Lu F., Wei X., Zhao R. Fucoidan: Structure and bioactivity. Molecules. 2008

  22. Kwak J.Y. Fucoidan as a marine anticancer agent in preclinical development. Mar. Drugs. 2014

  23. Ale M.T., Maruyama H., Tamauchi H., Mikkelsen J.D., Meyer A.S. Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo. Int. J. Biol. Macromol. 2011

  24. Marcel Tutor Ale, Hiroko Maruyama, Hidekazu Tamauchi, Jørn D Mikkelsen, Anne S Meyer, Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo